Skyrizi

View All

emerging-ulcerative-colitis-treatment-options
How the Novel Emerging Therapies Will Reshuffle the Ulcerative Colitis Treatment Dynamics?

Almost two decades ago, there were limited options for ulcerative colitis treatment. The readily available ulcerative colitis therapies were aminosalicylates and immunomodulators (azathioprine, 6-mercaptopurine, and methotrexate), with biologics (Adalimumab, Golimumab, infliximab, Ustekinumab, and Vedolizumab) rese...

Find More